EMERGENT BIOSOLUTIONS INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
EMERGENT BIOSOLUTIONS INC. (EBS) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $4.40 million as of 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2024-03-08
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $4.40M.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.00M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $60.70M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $54.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-12-31 | $4.40M 10-K · filed 2024-03-08 |
| 2022-12-31 | $12.00M 10-K/A · filed 2023-12-11 |
| 2021-12-31 | $60.70M 10-K · filed 2022-02-25 |
| 2020-12-31 | $54.40M 10-K · filed 2021-02-19 |
| 2019-12-31 | $37.00M 10-K · filed 2020-02-25 |
| 2018-12-31 | $32.80M 10-K · filed 2019-02-22 |
| 2017-12-31 | $17.90M 10-K · filed 2018-02-23 |
| 2016-12-31 | $18.00M 10-K · filed 2017-02-28 |
| 2015-12-31 | $20.00M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |